Full length antigen priming enhances the CTL epitope-based DNA vaccine efficacy

Cellular Immunology

Volumn 268, Issue 1, 2011, Pages 4-8

  Pouriayevali, Mohammad Hassan ^a   Bamdad, Taravat ^a   Parsania, Masoud ^b   Sari, Rohollah Dorostkar ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

CTL epitope; DNA vaccine; Full length antigen; HSV 1

Indexed keywords

DNA VACCINE; EPITOPE; GAMMA INTERFERON; GLYCOPROTEIN B; INTERLEUKIN 4; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY TEST; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES SIMPLEX VIRUS 1; IMMUNIZATION; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; MOUSE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGENS, VIRAL; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; CYTOKINES; EPITOPES, T-LYMPHOCYTE; HERPESVIRUS 1, HUMAN; IMMUNITY, CELLULAR; MALE; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

HUMAN HERPESVIRUS 1; MUS; SIMPLEXVIRUS;

EID: 79952486581     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.01.003     Document Type: Article

References (36)

1. Deshpand S.P., Kumaragur U., Rous B.T. Why do we lack an effective vaccine against herpes simplex virus infection?. Microbes infect 2000, 2:973-978.
2. Posavad C.M., Koelle D.M., Shaughnessy MF M.F., Corey L. Severe genital herpes infection in HIV infection individuals with impaired herpes simplex virus specific CD8+ cytotoxic T lymphocyte response. Proc. Natl Acad. Sci. USA 1997, 94:10289-10294.
3. Khanna K.M., Leisto A.J., Decman V., Hendricks R.L. Immune control of herpes simplex virus during latancy. Curr. Opin. Immunol. 2004, 16:463-469.
4. Lemieux P. Technological advance to increase immunogenicity of DNA vaccine. Expert Rev Vaccines 2002, 1:85-93.
5. Liu Margaret A., Wahren Britta, Karlsson Hedestam Gunilla B. DNA vaccine: recent developments and future possibilities. Hum. Gene Ther. 2006, 17:1051-1061.
6. Wilson C.C., Mckinneyn D., Anders M., Mawhinney S., Forster J., Crimi C., Southwood S., Sette Chesnut R., Newman M.J., Brian D. Livingston. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte T-lymphocyte responses to multiple conserved epitope in HIV. J. Immunol. 2003, 171:5611-5623.
7. Restifo N.P., Bacik I., Irvine K.R., Yewdell J.W., McCabe B.J., Anderson R.W., Eisenlohr L.C., Rosenberg S.A., Bennink J.R. Antigen processing in vivo and the elicitation of primary CTL responses. J. Immunol. 1995, 154:4414-4422.
8. Stanberry L.R., Jorgensen D.M., Nahmias A.J. Herpes simplex viruses 1 and 2. Viral Infection of Humans, Epidemiology and Control 1997, 419-454. Plenum medical Book Company, New York. fourth ed. A.S. Evans, R.A. Kaslow (Eds.).
9. Stanberry L.R., Spruance S.L., Cunningham A.L., Bernstein D.I., Mindel A., Sacks S., Tyring S., Aoki F.Y., Herpes vaccine efficacy study group, glycoprotein D adjuvant vaccine to prevent genital herpes N. Engl. J. Med. 2002, 347:1652-1661.
10. Koelle D.M., Corey L. Recent progress in herpes simplex virus immunobiology and vaccine research. J. Clin. Microbiol. 2003, 1:85-93.
11. Wallace M.E., Keating R., Heath W.R., Carbone F.R. The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice in almost directed against a signal immunodominant determinant. J. Virol. 1999, 73:7619-7626.
12. Bamdad T., Roostaee M.H., Sadeghizadeh M., Mahboudi F., Kazemnejad A., Soleimanjahi H. Immunogenicity and protective effect of a DNA construct encoding certain neutralizing epitopes of herpes simplex virus type-1 glycoprotein B. Folia Biol (Praha) 2005, 51:109-113.
13. Xiao S., Chen H., Fang L., Liu C., Zhang H., Jiang Y., Hong W. Comparison of immune responses and protective efficacy of suicidal DNA vaccine and conventional DNA vaccine encoding glycoprotein C of pseudorabies virus in mice. Vaccine 2004, 22:345-351.
14. Schmid I., Krall W.J., Uittenbogaart C.H., Braun J., Giorgi J.V. Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 1992, 13:204-208.
15. O'Brien M.C., Bolton W.E. Comparison of cell viability probes compatible with fixation and permeabilization for combined surface and intracellular staining in flow cytometry. Cytometry 1995, 19:243-255.
16. Koopman G., Reutelingsperger C.P., Kuijten G.A., Keehnen R.M., Pals S.T., van Oers M.H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994, 84:1415-1420.
17. Derby E., Reddy V., Kopp W., Nelson E., Baseler M., Sayers T., Malyguine A. Three-color flow cytometric assay for the study of the mechanisms of cell-mediated cytotoxicity. Immunol. Lett. 2001, 78:35-39.
18. Kim J.J., Nottingham L.K., Wilson D.M., Bagarazzi M.L., Tsai A., Morrison L.D., Javadian A., Chalian A.A., Agadjanyan M.G., Weiner D.B. DNA engineering vaccines via co-delivery of co-stimulatory molecule genes. Vaccines 1998, 16:1828.
19. Sette A., Fikes J. Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. Curr. Opin. Immunol. 2003, 15:461-470.
20. Wolkers M.C., Toebes M., Okabe M., Haanen J., Schumacher T.N. Optimizing the efficacy of epitope-directed DNA vaccination. J. Immunol. 2002, 168:4998-5004.
21. Rodriguez F., An L.L., Harkins S., Zhang J., Yokoyama M., Widera G., Fuller J.T., Kincaid C., Campbell I.L., Whitton J.L. DNA Immunization with minigenes, low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination. Virology 1998, 72:5174-5181.
22. Haan J., Bevan M.J. A novel helper role for CD4 T cells. PNAS 2000, 97:12950-12952.
23. Zhang S., Zhang H., Zhao J. The role of CD4 T cell help for CD8 CTL activation. Biochem. Biophys. Res. Commun. 2009, 384:405-408.
24. Keene J., Forman J. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J. Exp. Med. 1982, 155:768.
25. Zajac A.J., Blattman J.N., Murali-Krishna K., Sourdive D.J., Suresh M., Altman J.D., Ahmed R. Viral immune evasion due to persistence of activated T cells with-out effector function. J. Exp. Med. 1998, 188:2205-2213.
26. Maecker H.T., Umetsu D.T., DeKruyff R.H., Levy S. Cytotoxic T cell response to DNA vaccination: dependence on antigen presentation via class II MHC. J. Immunol. 1998, 161:6532-6536.
27. Mikloska A., Cunningham A.L. Herpes simplex virus type 1 glycoproteins gB, gC, and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes. J. Gen. Virol. 1998, 79:353-361.
28. Zarling J.M., Moran P.A., Burke R.L., Pachl C., Berman P.W., Lasky L.A. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD. J. Immunol. 1986, 136:4669-4673.
29. Toka F.N., Suvas S., Rouse B.T. CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1. J. Virol. 2004, 78:13082-13089.
30. Manickan E., Rouse R.J., Yu Z., Wire W.S., Rouse B.T. Genetic immunization against herpes simplex virus: protection mediated by CD4+ T lymphocytes. J. Immunol. 1995, 155:259-265.
31. Master J.C., Milligan G.N., Bernstein D.I. The immunobiology of herpes simplex virus. Genital and Neonatal Herpes 1996, 49-91. John Wiley and Sons, NY. L.R. Stanberry (Ed.).
32. Shedlock D.J., Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003, 5617:337-339.
33. She H., Whitmir J.K., Fa X., Shedloc D.J., Kaech S.M., Ahmed R. A specific role for B cells in the generation of CD8 T cell memory by recombinant Listeria monocytogenes. J. Immunol. 2003, 170:1443-1451.
34. Kursar M., Bonhagen K., Fensterle J., Köhler A., Hurwitz R., Kamradt T., Kaufmann S.H., Mittrücker H.W. Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses. J. Exp. Med. 2002, 196:1585-1592.
35. BenMohamed L., Krishnan R., Longmate J., Auge C., Low L., Primus J., Diamond D.J. Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice. dependence on HLA class II restricted TH response. Hum. Immunol. 2000, 61:764-777.
36. Ramsbur E.A., Publicover J.M., Coppock D., Rose J.K. Requirement for CD4 T cell help in maintenance of memory CD8 T cell responses is epitope dependent. J. Immunol. 2007, 178:6350-6358.